149 related articles for article (PubMed ID: 11981736)
21. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
Liuzzi G
Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
[TBL] [Abstract][Full Text] [Related]
22. Postexposure prophylaxis after sexual exposure to HIV.
Roland ME
Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
[TBL] [Abstract][Full Text] [Related]
23. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy.
Brewer DD; Golden MR; Handsfield HH
Sex Transm Dis; 2006 Apr; 33(4):250-5. PubMed ID: 16505748
[TBL] [Abstract][Full Text] [Related]
24. Men who have sex with men and human immunodeficiency virus/sexually transmitted disease control in China.
Liu H; Yang H; Li X; Wang N; Liu H; Wang B; Zhang L; Wang Q; Stanton B
Sex Transm Dis; 2006 Feb; 33(2):68-76. PubMed ID: 16432476
[TBL] [Abstract][Full Text] [Related]
25. HIV/AIDS in women: an expanding epidemic.
Quinn TC; Overbaugh J
Science; 2005 Jun; 308(5728):1582-3. PubMed ID: 15947174
[TBL] [Abstract][Full Text] [Related]
26. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models.
Boily MC; Bastos FI; Desai K; Mâsse B
Sex Transm Dis; 2004 Feb; 31(2):100-13. PubMed ID: 14743073
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of HIV disease: opportunities for new prevention interventions.
Fauci AS
Clin Infect Dis; 2007 Dec; 45 Suppl 4():S206-12. PubMed ID: 18190288
[TBL] [Abstract][Full Text] [Related]
28. [Prevention of vertical transmission of HIV in Denmark].
Rasmussen MB; Rasmussen JB; Nielsen VR; Herlin T; Fisker N; Hornstrup MK; Vinter H; Olofsson M; Weis NM
Ugeskr Laeger; 2008 Aug; 170(34):2567-70. PubMed ID: 18761841
[TBL] [Abstract][Full Text] [Related]
29. Integrating multidimensional HIV prevention programs into healthcare settings.
Temoshok LR; Wald RL
Psychosom Med; 2008 Jun; 70(5):612-9. PubMed ID: 18519883
[TBL] [Abstract][Full Text] [Related]
30. Genotypic resistance tests for the management of postexposure prophylaxis.
Puro V
Scand J Infect Dis Suppl; 2003; 106():93-8. PubMed ID: 15000596
[TBL] [Abstract][Full Text] [Related]
31. [Heterosexual transmission of HIV infection]].
Coulaud JP
Contracept Fertil Sex (Paris); 1993 Feb; 21(2):145-8. PubMed ID: 12318013
[TBL] [Abstract][Full Text] [Related]
32. Global epidemiology of sexually transmitted diseases.
Da Ros CT; Schmitt Cda S
Asian J Androl; 2008 Jan; 10(1):110-4. PubMed ID: 18087650
[TBL] [Abstract][Full Text] [Related]
33. Sex and reproduction among HIV-infected people in Maiduguri, Nigeria.
Chama C; Morrupa J; Gashau W
J Obstet Gynaecol; 2007 Nov; 27(8):812-5. PubMed ID: 18097901
[TBL] [Abstract][Full Text] [Related]
34. Trends in pregnancy rates among women with human immunodeficiency virus.
Blair JM; Hanson DL; Jones JL; Dworkin MS
Obstet Gynecol; 2004 Apr; 103(4):663-8. PubMed ID: 15051556
[TBL] [Abstract][Full Text] [Related]
35. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.
; ; ; ;
Clin Infect Dis; 2004 Jan; 38(1):104-21. PubMed ID: 14679456
[TBL] [Abstract][Full Text] [Related]
37. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency.
Resino S; Alvaro-Meca A; de José MI; Martin-Fontelos P; Gutiérrez MD; Léon JA; Ramos JT; Ciria L; Muñoz-Fernández MA
Pediatr Infect Dis J; 2006 Apr; 25(4):365-8. PubMed ID: 16567992
[TBL] [Abstract][Full Text] [Related]
38. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.
Neurath AR; Strick N; Li YY; Lin K; Jiang S
Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398
[TBL] [Abstract][Full Text] [Related]
39. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
[TBL] [Abstract][Full Text] [Related]
40. Behavioral interventions--rationale, measurement, and effectiveness.
Zenilman JM
Infect Dis Clin North Am; 2005 Jun; 19(2):541-62. PubMed ID: 15963887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
